Objective: We sought to estimate how serosorting may affect HIV prevalence and individual risk among men who have sex with men in Seattle, Washington, and how the results vary under different assumptions of HIV testing frequency, heterogeneity in sexual behavior, and condom use.
Introduction
Men who have sex with men (MSM) are the group most affected by HIV in the United States and many other nations and have dramatically changed their sexual behavior in response to the epidemic. Part of that change has involved preferentially selecting sex partners with concordant HIV status and preferentially using condoms with partners of discordant status [1] [2] [3] [4] . These practices have been termed serosorting. Some research suggests that serosorting is increasing [5] [6] [7] [8] and may explain stable or declining HIV infection rates among MSM even as rates of bacterial sexually transmitted infections (STIs) have risen dramatically [9] .
Serosorting is controversial. A 2007 paper used a static model to suggest that serosorting might actually increase one's risk of HIV acquisition because of the high transmission probability during early HIV infection [10] when most men are undiagnosed. In contrast, case-control and cohort studies suggest that serosorting affords men partial protection against HIV infection [7, [11] [12] [13] [14] [15] .
Using population-based behavioral surveillance data and mathematical modeling, we sought to evaluate the population-level and individual-level effects of serosorting among MSM in Seattle, Washington and to define factors influencing how serosorting affects HIV transmission dynamics [16] .
Transmission
Transition from true negative into acute NAATÀ/EIAÀ infection occurs via transmission, a potential consequence of anal sex with a true positive. We define 'act' as an instance of anal sex, 'contact' as the set of acts between two men, 'contact rate' as the rate of new contacts, and 'partner' as either member of a contact. The contact rate between true negatives and true positives is determined by the apparent negative and diagnosed positive contact rates, level of serosorting, and fraction of apparent negatives who are true positives. We derive all but the last parameter from our data on respondents' activity levels and respondents' and their partners' apparent serostatus.
The RDD study asked men to enumerate their contacts in the prior year. We defined low-activity men as those reporting one contact in that period and high-activity men as those reporting more than one contact. Highactivity men reported a mean of 10 contacts. Lacking data on partner's activity level, we assume random mixing by activity level. We also assume that men who have ever tested positive report themselves as positive and all others report themselves as negative.
In our baseline run, we assume levels of serosorting within various types of contacts consistent with our data, as measured by two odds ratios: the odds that a low-activity diagnosed positive's partner is diagnosed positive is 68 times greater than the odds that a low-activity apparent negative's partner is diagnosed positive; and the comparable odds ratio for high-activity men is 12. Although population size and composition change over time, our approach ensures that these two directly measured components of serosorting remain constant, as do overall contact rates by compartment. By focusing on counts of anal sex contacts by serostatus, we include two processes within our definition of serosorting: use of serostatus in selecting sex partners and in selecting sex act (anal vs. other). For clarity, we define differential adoption of condom use by perceived serostatus as status-based condom use. These two definitions are often combined; we model them separately to disentangle their effects on HIV risk.
Within serodiscordant contacts, transmission probability depends on the seropositive's stage and treatment status, number of acts per contact, seropositive's role (insertive/ receptive), and condom use. As there are no published estimates of penile-anal transmission probabilities by infection stage, we derived stage-specific and role-specific estimates by taking relative stage-specific estimates for heterosexuals [17] and scaling them according to overall MSM anal sex estimates [18] . Acts per contact and role by serostatus are derived from the RDD (Table 1 ) [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] .
Transition through disease stage
We assume men average 7 days from infection to detectable HIV-RNA [19] and 35 additional days to detectable anti-HIV antibody [20] . Primary infection concludes 48 days later, for a 3-month total duration of heightened infectiousness [17] . Without treatment, chronically infected individuals develop AIDS after 10 years [21] . With treatment, AIDS progression reduces by 0.6 [22] .
Diagnosis
Our base model assumes low-activity men average one EIA test/year, and high-activity men average two [16] .
Treatment
Sixty-seven percent of HIV-positive RDD participants reported taking ART [16] . We assume that men discontinue ART because of treatment failure or side effects at 0.02/year [23] . Recent reports indicate that ART reduced HIV transmission by 80-100% among serodiscordant African couples [24, 25] and by 60% among MSM [26]; we adopted this latter, more conservative, estimate.
Entry and exit
Men remaining truly negative average 50 years in the sexually active population. Upon developing AIDS, men survive on average 2 years if untreated [17, 22] ; treatment reduces AIDS mortality by 0.6 [22] . For convenience, entries by activity level equal exits.
Initial conditions
At model outset, three low-activity men and three highactivity men are HIV-positive; in each group, one is EIAÀ/NAATÀ, one EIAÀ/NAATþ and undiagnosed, and one EIAÀ/NAATþ and diagnosed. All other men are HIV-negative, distributed according to the activity class distribution described in Table 1 .
Parameterization
Our baseline run was parameterized by our data; this yielded an endemic HIV prevalence within the prevalence range estimated for our population, which we considered confirmatory evidence for model and data quality. We then ran the model varying parameter values reflecting hypothetical scenarios of interest. 
Results
Our baseline model considers the epidemic using our observed data, including observed serosorting and statusbased condom use levels. Equilibrium prevalence is 16.0%, within the range estimated for Seattle MSM [13%; 95% confidence interval (CI): 10-17%]. By eliminating serosorting (i.e. maintaining overall contact rates for apparent negatives and for diagnosed positives, but making contact and sex act selection random by apparent serostatus), equilibrium prevalence rises to 24.6%. Serosorting appears to result in lower incidence of HIV among this population.
With serosorting, 22% of contacts are apparently serodiscordant, compared with 50% without serosorting. The proportion of apparent negative-negative contacts in which one partner is actually undiagnosed positive is lower in the model with serosorting (2.3%) than without (4.8%), reflecting difference in HIV incidence (1.1 vs. 1.7% per year, respectively). However, the proportions of infections resulting from all undiagnosed men and from undiagnosed, recently infected (<3 months) men are higher in the model with serosorting (48.6 and 30.6%, respectively) than without (26.3 and 16.5%, respectively). This last pattern holds qualitatively for all additional models described below.
Individual-level risk of acquiring HIV from an unprotected anal sex act with an apparent negative is also lower in the baseline serosorting scenario. At equilibrium, transmission probabilities during unprotected receptive anal intercourse (URAI) and unprotected insertive anal For these parameters, our data provide us with two estimates: one for low-activity men and high-activity men. However, our model requires three parameters defined on activity levels for actor pairs (HH, HL, LL). The method we use to derive these three parameters from the two observed data points is identical for each parameter class and is described in the online appendix.
intercourse (UIAI) with a randomly chosen apparent negative (weighted by those men's activity levels) in the serosorting scenario are 0.00028 and 0.00008, respectively. Comparable rates in the absence of serosorting are 0.00060 and 0.00016, approximately twice as high. UAI with a diagnosed positive is far more risky than with an apparent negative; under serosorting, the probability of acquiring HIV from URAI and UIAI with a randomly chosen diagnosed positive equals 0.0050 and 0.00046, respectively (17.9 and 6.1 times the apparent negative rates). The rates did not change in the no-serosorting scenario. Figure 2 shows equilibrium prevalence for various contact rates (produced by increasing each group's contact rate by an equal fraction). We model scenarios with ( Fig. 2a ) and without ( Fig. 2b ) condom use in perceived seroconcordant contacts (see Table 1 for condom usage rates in baseline model). Figure 2a includes our two baseline scenarios (mean contact rate ¼ 3.76; equilibrium prevalence ¼ 16.0% with serosorting and 24.6% without). Equilibrium prevalence remains lower for serosorting than equivalent no-serosorting scenarios when contact rates are less than 7.0/year; men would need an 86% increase above observed contact rate to abrogate the protective effects of serosorting.
We conducted additional simulations incorporating no condom use in perceived concordant contacts ( Fig. 2b ). Equilibrium prevalence remains lower for serosorting than equivalent no-serosorting scenarios when contact rates are less than 4.9/year. Under these assumptions, men would need a 30% increase in contact rate above that observed in Seattle to abrogate the protective effects of serosorting.
We consider various levels of status-based condom use in perceived discordant and concordant contacts ( Fig. 3a HIV serosorting as a harm reduction strategy and b). In the baseline model, 31 and 49% of sexual acts were protected with condoms in perceived discordant and concordant contacts, respectively. (These counterintuitive rates of condom use may be due to hidden heterogeneity in men's risk tolerance, i.e. risk-prone men are likely both to have discordant partnerships and forgo condoms.) Equilibrium prevalence is consistently higher in the no-serosorting scenarios for all levels of condom use in either perceived discordant or perceived concordant contacts. In this scenario, serosorting's protective efficacy results primarily from preferential selection of apparent negative partners by apparent negative men. However, as condom use in perceived concordant contacts decreases, the difference in prevalence between the serosorting and no-serosorting scenarios decreases as well, from a 12% difference at 90% coverage to a 5% difference at 10% coverage. Thus, the more condoms are used in perceived concordant negative contacts, the bigger the protective effect of serosorting. Given reported contact rates, were men not to serosort, they would need to increase condom use to 90% in perceived discordant contacts to achieve the prevalence observed in the baseline serosorting scenario. No level of condom use among perceived concordant contacts would achieve the same result.
We note five observations of the effect of testing frequency on the relationship between serosorting and HIV equilibrium prevalence. First, in the absence of any testing (i.e. no serosorting, status-based condom use or ART, as status is unknown), equilibrium prevalence is 40%. Second, equilibrium prevalence declines as testing frequency increases ( Fig. 4 ). However, there are diminishing marginal returns with increasing testing frequency for high-activity men. Third, in scenarios in which all men test once every 2 years, equilibrium prevalence under assumptions of serosorting is greater than under no serosorting; however, with more frequent Additional sensitivity analyses (not shown) revealed that higher estimates of transmission probability during primary stage decreased the benefits of serosorting. Increasing the primary/chronic ratio of transmission probabilities by 10% decreased serosorting's effect on endemic prevalence from 8.6 to 7.5%, whereas decreasing the ratio by 10% increases the difference to 9.3%. A longer duration of heightened primary infection also decreases the benefit: HIV prevalence would be 7.3% higher without serosorting if the primary stage lasted 4 months, whereas the change in prevalence would be 9.9% if the primary stage lasted 2 months. Lastly, shortening the duration of sexual activity from 50 to 30 years did not change the estimated effect of serosorting.
Discussion
Our model suggests that serosorting (differential selection of sex partners or sex acts -anal vs. oral -by perceived HIV status), combined with status-based condom use, is highly protective at both the individual and population level among MSM. The protective effect of these behaviors remains true under a wide range of scenarios, at least relative to partner selection or condom use without regard to HIV status. However, in the Seattle MSM scenario, almost half of infections are transmitted by men undiagnosed for HIV. These findings have implications both for understanding HIV transmission and for prevention.
The finding that serosorting is protective is consistent with most epidemiologic studies evaluating HIV acquisition risk among MSM. These studies have consistently found that the greatest risk of acquiring HIV through UAI is associated with having HIV-infected partners, followed by partners of unknown HIV status and lowest with partners thought to be HIV-uninfected [11, 13, 14] . However, our results differ from those reported in an earlier modeling study [10] that found that serosorting could be detrimental. In large measure, these divergent findings reflect the different assumptions underlying the models. The authors of the previously published model assumed that the prevalence of recent (<6 months) seroconversion among all negative disclosers was 4% and that no apparent negatives used condoms with men they believed to be HIV-negative [10] . In our model, prevalence of recent HIV is around 1.2% if one defines recent as less than 6 months or about 0.5% given our assumption of a 3-month primary stage. Moreover, many HIV-negative MSM use condoms with apparently negative partners. Had we assumed no condom use in apparent seroconcordant contacts and that 4% seronegative disclosers were acutely infected (by artificially increasing mean contact rate to 5.64 -a 67% increase), our model would also have found that serosorting is detrimental.
To place our findings into context, if Seattle MSM were to abandon serosorting as a practice and choose partners and sex acts randomly by apparent serostatus, they would need to reduce contact rates by 30% or increase condom use with apparently discordant contacts by 50% to prevent an increase in transmission.
Our findings have several prevention implications. First, they should not be construed to suggest that efforts to actively promote serosorting are justified. It is imperative to bear in mind that our scenarios considered serosorting relative to not serosorting, with all other behaviors held equal. That is, for an HIV-negative man to choose an apparently HIV-negative partner for UAI is highly protective relative to choosing a partner without regard to HIV status. However, UAI with an apparently HIVnegative man is more risky than consistent condom use and may be more risky than either protected anal intercourse or oral sex with an apparently HIV-positive man. Also, concordant UAI between apparent negatives within a stable relationship with 'negotiated safety' is safer than concordant UAI between causal partners [12] . Risk is complex, and the implications of increased serosorting, for both individual and population, depend on what behaviors the practice replaces. Attempts to promote serosorting as a harm reduction strategy, particularly among HIV-negative men, need to consider the hierarchy of risk and the extent to which an increase in serosorting represents a move up or down that hierarchy. This process is more straightforward when considering promotion of serosorting among diagnosed positives than apparent negatives. In the former case, adoption of serosorting cannot increase transmission of HIV to seronegatives regardless of which behavior it is replacing, whereas in the latter case it can. Recent studies have indeed tended to observe larger increases in serosorting among diagnosed positive MSM than among apparent negatives [6, 7] . Note, however, that promotion of serosorting among positives is not without potential tradeoffs, given the possibility of superinfection or transmission of other STIs [28, 29] .
Second, recognition of serosorting as an informal risk reduction strategy should prompt efforts to promote more frequent HIV testing and the widespread use of more sensitive assays. Although serosorting appears to generally reduce HIV prevalence, it also increases the proportion of new HIV infections transmitted by undiagnosed individuals, including from those recently infected. Consequently, serosorting may be a detrimental practice at very low testing frequencies. Our findings suggest that increasing testing frequency among highly sexually active MSM from once every 2 years to four times per year, coupled with the use of NAATs, could reduce equilibrium prevalence of HIV by over 50%. Although NAAT testing has not been widely adopted in the United States, recent studies suggest that a combined antigen-antibody EIA that is already available in Europe and that could easily replace existing assays in the United States would likely identify the vast majority of antibody-negative infections [28, 30] .
Our work relies on self-reports of perceived partner status. Unlike many other cases in which self-reports are inherently limiting, here they are appropriate because serosorting occurs on the basis of individuals' beliefs about their potential partners' serostatus rather than the actual status. We did not, however, include the possibility that individuals might knowingly misrepresent their serostatus [29] . In our RDD study, two of 37 (5%) HIVpositive men and four of 189 (2%) HIV-negative men who had anal sex in the prior year reported misrepresenting their HIV status. This misrepresentation would reduce the protective effect of serosorting. On the other hand, nondisclosure of HIV status would most likely increase the protective effect of serosorting. In our model, we assume that nondisclosers' actual HIV status is representative of the HIV distribution in the population, and nondisclosers are chosen as partners at the same rate as HIV-positive and negative individuals. If instead we assumed that nondisclosers were refused as partners and not replaced by others, the odds ratio of serosorting would increase, as would the protective effect. However, to properly test the effect of nondisclosure, a serosorting model would need a two-step process: HIV status disclosure; and the decision whether to engage in an anal sex act. This could be difficult, as data are not usually collected on potential partners who were refused.
In modeling the effect of testing frequency on HIV, we did not consider the motivation for testing; whereas some MSM test on a regular basis regardless of risk, others may be spurred to test by specific risk events and symptoms of acute HIV infection [31] . In our model, we only consider the former; future work should consider the latter as well. Doing so would likely require use of an agent-based model.
We further assumed random mixing among men by activity class, partly for lack of data and partly for model simplicity, although in truth some level of assortative mixing is likely. We expect that including assortative mixing in the model might slightly decrease the effectiveness of serosorting by creating a 'core group' of assortatively mixing high-activity men whose presence increases the size of the epidemic and thus of the proportion of apparent negatives who are actually acutely infected at any time.
Additionally, we considered only a lower bound estimate for reduction of HIV transmission associated with ART and did not consider transmission effects of early treatment. Because serosorting increases the proportion of infections stemming from acutely infected individuals, early ART may further increase the protective effects of serosorting at the population-level and individual-level. Future modeling work should explore this topic.
Despite the paucity of existing data on the benefits of serosorting, some public health programs and communitybased organizations now promote the practice [32] . Our data and model suggest that under realistic scenarios of sexual behavior and testing frequency for MSM in the United States, serosorting can be an effective harm reduction strategy. However, the impact of serosorting promotion remains uncertain and will depend on what behaviors MSM abandon as they adopt the practice. In contrast, the benefits of increasing the frequency of HIV testing and using the most sensitive available HIV tests are straightforward and these interventions should be widely promoted.
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We The model is described in ten sections: (1) overview of the differential equations; (2) mixing and contact rates; (3) infectivity per contact (including acts, role and condom use); (4) total number of new infections per compartment (lambda); (5) disease progression; (6) diagnosis; (7) treatment; (8) entrance and exit; (9) initial conditions; (10) derivation of partnership-level parameters from individual-level data; and (11) statement of the resulting system of ordinary differential equations Throughout the derivation below, we refer to men's ''true serostatus'' (true negative vs. true positive) as well as their apparent serostatus (AN = apparent negatives, i.e. men who are either true negatives or undiagnosed positives; DP = diagnosed positives). We also define ''act'' as an an act of anal sex between two men; and ''contact'' as the set of all acts between a pair of men.
(1) Overview of the differential equations
The mathematical model is specified by twenty-four nonlinear ordinary differential equations that capture the sexual behavior and mixing patterns of MSM in Seattle, WA and the natural history of untreated and treated HIV infection in a population of MSM. These equations assume linear hazards for all processes other than HIV transmission (e.g. entry and exit from the population, movement between stages of infection, and diagnosis). The infection process, however, is governed by a nonlinear process that depends upon the patterns of mixing between men of HIV-negative and HIV-positive HIV status. The infection process additionally depends on the HIV transmission probability per act, which varies by sexual role, stage of infection, and treatment status; the number of acts per contact; the proportion of acts that are receptive and insertive; and, the proportion of acts during which condoms are used (See Table 1 in the published manuscript).
All state variables in the following derivation should be indexed by time; however, we leave this notation off for the sake of simplicity. 
Contact counts
We define serosorting for any set of men as the level of assortative mixing by apparent serostatus for those men. We quantify assortative mixing using the odds ratio in a 2x2 serostatus mixing matrix. To do so, we follow a method of Goodreau [1] , described below, that allows us to calculate cell counts based on this odds ratio and the marginal totals of the mixing matrix, the latter of which change through time as compartment sizes change. For a binary attribute only, this approach provides analytical solutions that are equivalent to earlier methods using loglinear modeling to capture assortative mixing [2] . The method yields a measure of assortative mixing whose statistical properties are clear, which is comparable to other measures of interest to epidemiologists (since it is an odds ratio), and which results in behavior in the mixing matrix through time that clearly separates the mixing biases from the effects of population composition. These features distinguish the approach from other methods such as a fixed in-group proportion bias. Note also that this approach, by explicitly counting contacts at every step, ensures balance of all types, in the sense that the total number of contacts at any time that men of class i have with class j equals the number that men of class j have with class i, for all classes i and j.
For example, imagine a matrix of one-time contacts:
receptive partner
Here a would represent the number of contacts in which both the insertive and receptive partner are seronegative; likewise for the other cell entries. The odds ratio ad/bc would be greater than 1 when men are more likely than chance to have partners of the same serostatus, less than 1 when less likely, and 1 when mixing is random. The relative ratio of b and c provides a measure of the level of seropositioning. Our goal is to maintain the overall ondiagonal bias (as measured by the odds ratio) as the margins change (for instance, due to changing numbers of men of different serostatuses).
In our data, we are modeling longer-term as well as shorter-term contacts, and not all contacts can be neatly divided into an insertive and a receptive partner. However, since square matrices are far more tractable than triangular ones, we arbitrarily (and temporarily) assign the two men in a contact to represent ''member 1'' (row) and ''member 2'' (column).
Let us define C A1S1,A2S2 as the total number of new contacts per unit time in which member 1 is in activity class A1 and apparent serostatus S1 and member 2 is in activity class A2 and apparent serostatus S2.
We can arrange the 16 different C values in four 2x2 matrices: one for each combination of two men by activity level (LL, LH, HL, HH), where the rows represent member 1 and the columns represent member 2: That is, the LL and HH matrices are each symmetric, while the LH and HL matrices are transposes of each other. Thus, we effectively have 10 unknowns instead of 16.
Marginal constraints
We define T as as the total number of new contacts per unit time for men of activity class a and apparent serostatus s. We also define k(x) as the average rate of new contact acquisition per unit time for a man in compartment x, where x represents any possible compartment. Thus:
T LN = total number of new contacts per unit time for low-activity AN men
T HN = total number of new contacts per unit time for high-activity AN men
T LP = total number of new contacts per unit time for lowactivity DP men
T HP = total number of new contacts per unit time for high-activity DP men The assumption of random mixing by activity level means that we can fill in the margins of the tables thus: 
/2T T LN T H /2T T LP T H /2T T HN T H /2T T HP T H /2T
For example, the sum of the first row of the first table represents the total number of contacts that ''member 1'' men who are low-activity AN have with all low-activity men, regardless of member 2's apparent serostatus. To derive an expression for this, we first calculate the total number of contacts that low-activity AN ''member 1'' men have overall. Given the arbitrariness of the ordering, this number is half that of all contacts for low-activity AN men, or T LN /2. Under the assumption of random mixing by activity level, the proportion of these contacts that occur with low-activity men is T L /T, and the final count is thus T LN T L /2T.
These constraints yield a system with three degrees of freedom remaining for determining the values of the above 2x2 cell entries. The three degrees of freedom match the three odds ratios that we wish to fix for the matrices: those in the LL, LH, and HH matrices, which we call OR LL , OR LH , and OR HH , respectively. (The HL matrix odds ratio must equal the LH one, since the matrices are transposes of each other).
Serosorting constraints
We do not directly observe estimates for OR LL , OR LH , and OR HH in our data, since our surveys did not ask respondents about the activity levels of their partners. However, we do observe the odds ratios for two 2x2 tables that are functions of OR LL , OR LH , and OR HH : the reports by low-activity men of all their contacts by apparent serostatus, and the same reports for high-activity men. We call these odds ratios OR L and OR H , respectively. Since these are our direct measures of serosorting, we wish to hold these values constant in any given run of the model so as to have a clear understanding of how our populations relate to that from which our data are drawn.
These two additional constraints mean that there is still one degree of freedom remaining; that is, there are multiple sets of values for the three odds ratios in the tables above that will solve the system. In practice, however, these vary over only a small range. For realistic populations, OR HH can fall only within a small range close to our observed value of OR H; the bulk of highactivity men's contacts are with other high-activity men, since they represent the vast majority of the contact opportunities in the population. Likewise we find in practice that OR LH must be close in value to OR L . For any single run of the model, we assume an odds ratio for OR LH of 60.
Given this information, there is a unique solution for all ten variables that will match our data for OR L (= 68) and OR H (= 12) . The values in the heterogeneous activitylevel tables must equal:
(Derivation follows Goodreau [1] , and is available from the corresponding author upon request.)
To obtain values for the LL matrix cell entries, we turn to the reports in our data from low-activity respondents. As previously mentioned, we can create a 2x2 table of these men's serostatus by that of all their partners, and define the odds ratio of this table as OR L . We can then imagine creating a table for our modeled population with the same structure:
All of their contacts À + Lowactivity men where the rows represent the serostatus of the respondent (always low) and the columns represent the serostatus of their contacts (both low and high). The expected value of the odds ratio for a random sample of low-activity men drawn from this population equals the odds ratio in the population. Thus, we assume that the odds ratio in the full census equals that in our sample (OR L ), yielding the following constraint: yields three unknowns in three equations. The unique solution to this system is: the solution to which is: We are now prepared to eliminate the ordering of the partners within our contacts. Define C a1s1a2s2 (without a comma) as the number of new contacts per unit time between one man of activity class a1 and apparent serostatus s1, and another man of activity class a2 and apparent serostatus s2. Thus: All of these contact types may involve transmission, since some AN men are actually positive and some negative.
Only contact types between two diagnosed positives cannot.
We now wish to derive expressions for the number of actual serodiscordant contacts that true negative men of each activity class have with either undiagnosed or diagnosed positives of each activity class. Let us define C LTN,LUP as the number of contacts that low-activity true negative men have with low-activity undiagnosed positive men at a give time; and likewise for all other combinations of interest. Then: The two appears in the first and fourth entries because of the homogeneous nature of these types of contacts (C LNLN and C HNHN ); in each, there are two ways in which one member could be a true seropositive and the other be a true seronegative, and yield a transmission event to the category of interest. Note that the analogous quantity C LNHN also appears twice, one time each in two different equations. Another way to understand the presence of the two in these expressions and not the others is to consider that these contact types (C LNLN and C HNHN ) are the only ones containing a single element in their definitions above rather than being the sum of two elements.
Because we assume random (non-assortative) mixing by HIV stage and treatment status, we can partition these numbers out to obtain the number of new contacts per unit time between two men in any pair of serodiscordant compartments. Define A as any true negative compartment and B as any true positive compartment. Define s(B) as the combined attributes of B (i.e. activity-level, apparent serostatus and diagnosis status). Then:
GkðGÞ :
For example:
Contact rates for all of the 2x22= 44 different serodiscordant combinations can be calculated analogously.
(3) Infectivity per contact (including acts, role and condom use)
Infectivity per true serodiscordant contact is a function of the stage of infection and treatment status of the true positive partner, the number of acts within the contact, the sexual role (insertive/receptive) adopted by each man during these acts, and condom use during these acts.
Men engage in n i,j anal sex acts per contact depending on the activity class i of the true negative partner and activity class j of the AN or DP partner, and whether they are in an apparent seroconcordant or serodiscordant contact. For the proportion, Pins i,j , of those acts, the true negative partner is the insertive partner and for the proportion, 1-Pins i,j , of those acts, he is the receptive partner. HIV transmission probability per unprotected receptive act, b rec , is 0.02 in primary infection (m = 1), 0.008 in chronic infection (m = 2), and 0.01 in AIDS (m = 3) and HIV transmission probability per unprotected insertive act, b ins, is 0.008 in primary infection, 0.0007 in chronic infection, and 0.001 in AIDS. For contacts in which the true positive man is treated (t = 1), ARV reduces infectiousness by a fraction, e T . Condom use reduces the probability of transmission by a fraction e C . The proportion of acts protected by condoms, C, varies by apparent seroconcordance (k = 1) or serodiscordance (k = 0), sexual role, and the activity classes of the members of the contact. We adopt a binomial model to calculate infectivity per true serodiscordant contact: For information on the values that we adopt for the many variables included in this equation, and the data sources for them, see Table 1 in the published manuscript. Upon infection men enter the U stage, during which HIV undergoes local replication in lymph nodes but has not yet entered the bloodstream. Therefore, HIV RNA has yet to reach detectable levels by pooled nucleic acid amplification testing (NAAT) and antibody is not detectable by second generationEIA.Theaveragedurationspentinthisstageis1/ n = 7 days. Early infection where HIV RNA becomes detectable but there is still no detectable antibody lasts 1/r = 35 days. The duration of early infection where both RNA and antibody are detectable but HIV viral load is still high is 1/k = 48 days. Therefore, primary HIV infection averages 3 months. Untreated men with chronic infection progress to AIDS after a long incubation period (1/g = 10 years).
(6) Diagnosis
The diagnosis of HIV infection depends on rates of testing and type of HIV testing in the population. Based on 2003 RDD data, low-activity men test for HIV by second generation EIA once each year (u L ), while high-activity men test by EIA twice each year (u H ). An EIA will become positive 6 weeks post infection. We include NAAT at the same frequency as EIA testing in the lowand high-activity men (t L , t H ). We then explore scenarios where low-activity men test by EIA and NAAT up to twice per year and high-activity men test by EIA and NAAT up to four times per year.
(7) Treatment
In this model, men with both chronic infection and AIDS are treated with antiretroviral therapy (ART) with equal rates of initiation r, that differ by activity class. The effect of ART in treated individuals is modeled by assuming that it slows the rate of disease progression by the fraction e P (0.60), and reduces mortality due to AIDS by the fraction e M (0.60).
Men with chronic infection and AIDS initiate treatment at an annual rate r, 0.15 years -1 . Treatment failure and cessation and withdrawal from treatment is allowed to occur at an annual rate v, 0.02 years -1 . Under these initiation and withdrawal rates, the proportion of all HIVpositive men on treatment is 67%, which corresponds to the 2003 Seattle RDD data.
(8) Entrance and exit
In our model, men are sexually active for an average of 50 years. Men diagnosed with AIDS die on average 2 years after their diagnosis, and treatment reduces mortality due to AIDS as described in Section 7. For simplicity, the rate of entrance into the population is identical to the rate of exit from the population. There are numerous parameters that our model defines at the level of the contact or actor pair, but which our data provide at the level of the individual only. For instance, we have reports from low-activity men and from highactivity men of their mean number of unprotected acts within perceived serodiscordant contacts. Since we are modeling three kinds of contacts by activity level (lowlow, low-high, high-high) we need three rates. In each case, we assume that the values for low-low contacts and low-high contacts both equal the value observed for lowactivity respondents. We then use the value for the highhigh contacts such that when one calculates an average value for all high-activity men (via a weighted average of high-high and low-high contacts), it matches our oserved data. The selection of this assumption was motivated by the fact that high-high and low-high contacts comprise the vast majority of the contacts in the population (since high men are more numerous than low and have 10 times more contacts); this method ensures that these two fall close to the observed numbers and that the weighted averages exactly equal the two observed data points. For instance, our data included:
